Self-renewal versus differentiation in hematopoietic stem and progenitor cells: A focus on asymmtric cell divisions

Current Stem Cell Research and Therapy

Volumn 3, Issue 1, 2008, Pages 9-16

  Giebel, Bernd ^a   Bruns, Ingmar ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

AC133; Asymmtric cell division; CD133; CD34; CD53; CD62L; CD63; CD71; L selectin; Leukaemia; Prominin 1; Tetraspanin; Tetraspanins; Transferrin receptor

Indexed keywords

BETA CATENIN; CD133 ANTIGEN; CD34 ANTIGEN; CYCLIN A; CYCLIN E; NOTCH RECEPTOR; PLAKOGLOBIN; PROTEIN BRAT; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR PROSPERO; TUMOR SUPPRESSOR PROTEIN; WNT PROTEIN;

ACUTE GRANULOCYTIC LEUKEMIA; ANTIGEN EXPRESSION; ANTIGEN PRESENTING CELL; CANCER STEM CELL; CELL DEGENERATION; CELL DIVISION; CELL EXPANSION; CELL FUNCTION; CELL INTERACTION; CELL RENEWAL; CELL TRANSFORMATION; CHRONIC MYELOID LEUKEMIA; DISEASE MARKER; DROSOPHILA MELANOGASTER; HEMATOPOIETIC STEM CELL; HUMAN; IN VIVO STUDY; LEUKEMIA; LEUKEMOGENESIS; NEURAL STEM CELL; NEUROBLAST; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN TARGETING; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE;

ANIMALS; CELL DIFFERENTIATION; CELL DIVISION; CELL PROLIFERATION; DROSOPHILA; HEMATOPOIETIC STEM CELLS; HUMANS; LEUKEMIA; MODELS, BIOLOGICAL; STEM CELLS;

EID: 47749148900     PISSN: 1574888X     EISSN: None     Source Type: Journal    
DOI: 10.2174/157488808783489444     Document Type: Review

References (126)

1. Yu F, Kuo CT, Jan YN. Drosophila neuroblast asymmetric cell division: recent advances and implications for stem cell biology. Neuron 2006; 51: 13-20.
2. Morrison SJ, Kimble J. Asymmetric and symmetric stem-cell divisions in development and cancer. Nature 2006; 441: 1068-74.
3. Betschinger J, Knoblich JA. Dare to be different: asymmetric cell division in Drosophila, C. elegans and vertebrates. Curr Biol 2004; 14: R674-85.
4. Wodarz A, Huttner WB. Asymmetric cell division during neurogenesis in Drosophila and vertebrates. Mech Dev 2003; 120: 1297-309.
5. Roegiers F, Jan YN. Asymmetric cell division. Curr Opin Cell Biol 2004; 16: 195-205.
6. Yamashita YM, Fuller MT, Jones DL. Signaling in stem cell niches: lessons from the Drosophila germline. J Cell Sci 2005; 118: 665-72.
7. Li L, Xie T. Stem cell niche: structure and function. Annu Rev Cell Dev Biol 2005; 21: 605-31.
8. Lin H. The stem-cell niche theory: lessons from flies. Nat Rev Genet 2002; 3: 931-40.
9. Nystul TG, Spradling AC. Breaking out of the mold: diversity within adult stem cells and their niches. Curr Opin Genet Dev 2006; 16: 463-8.
10. Spradling A, Drummond-Barbosa D, Kai T. Stem cells find their niche. Nature 2001; 414: 98-104.
11. Al-Hajj M. Cancer stem cells and oncology therapeutics. Curr Opin Oncol 2007; 19: 61-4.
12. Beachy PA, Karhadkar SS, Berman DM. Tissue repair and stem cell renewal in carcinogenesis. Nature 2004; 432: 324-31.
13. Reya T, Morrison SJ, Clarke W, Weissman IL. Stem cells, cancer, and cancer stem cells. Nature 2001; 414: 105-11.
14. Wagers AJ, Conboy IM. Cellular and molecular signatures of muscle regeneration: current concepts and controversies in adult myogenesis. Cell 2005; 122: 659-67.
15. Taupin P, Gage FH. Adult neurogenesis and neural stem cells of th central nervous system in mammals. J Neurosci Res 2002; 69: 745-9.
16. Kamminga LM, de Haan G. Cellular memory and hematopoietic stem cell aging. Stem Cells 2006; 24: 1143-9.
17. Anversa P, Rota M, Urbanek K, et al. Myocardial aging-a stem cell problem. Basic Res Cardiol 2005; 100: 482-93.
18. Korbling M, Anderlini P. Peripheral blood stem cell versus bone marrow allotransplantation: does the source of hematopoietic stem cells matter? Blood 2001; 98: 2900-8.
19. Bensinger WI, Buckner D, Gahrton G. Allogeneic stem cell transplantation for multiple myeloma. Hematol Oncol Clin North Am 1997; 11: 147-57.
20. Ballen KK. Now trends in umbilical cord blood transplantation. Blood 2005; 105: 3786-92.
21. Ringden O, Le Blanc K. Allogeneic hematopoietic stem cell transplantation: state of the art and new perspectives. APMIS 2005; 113: 813-30.
22. Iscove NN, Nawa K. Hematopoietic stem cells expand during serial transplantation in vivo without apparent exhaustion. Curr Biol 1997; 7: 805-8.
23. Civin CI, Almeida-Porada G, Lee MJ, Olweus J, Terstappen LW, Zanjani ED. Sustained, retransplantable, multilineage engraftment of highly purified adult human bone marrow stem cells in vivo. Blood 1996; 88: 4102-9.
24. Bhatia M, Wang JC, Kapp U, Bonnet D, Dick JE. Purification of primitive human hematopoietic cells capable of repopulating immune-deficient mice. Proc Natl Acad Sci U S A 1997; 94: 5320-5.
25. Zanjani ED, Almeida-Porada G, Livingston AG, Flake AW, Ogawa M: Human bone marrow CD34- cells engraft in vivo and undergo multilineage expression that includes giving rise to CD34+ cells. Exp Hematol 1998; 26: 353-60.
26. Bhatia M, Bonnet D, Murdoch B, Gan OI, Dick JE. A newly discovered class of human hematopoietic cells with SCID-repopulating activity. Nat Med 1998; 4: 1038-45.
27. Gallacher L, Murdoch B, Wu DM, Karanu FN, Keeney M, Bhatia M. Isolation and characterization of human CD34(-)Lin(-) and CD34(+)Lin(-) hematopoietic stem cells using cell surface markers AC133 and CD7. Blood 2000; 95: 2813-20.
28. Hofmeister CC, Zhang J, Knight KL, Le P, Stiff PJ. Ex vivo expansion of umbilical cord blood stem cells for transplantation: growing knowledge from the hematopoietic niche. Bone Marrow Transplant 2007; 39: 11-23.
29. Shimizu Y, Ogawa M, Kobayashi M, Almeida-Porada G, Zanjani ED. Engraftment of cultured human hematopoietic cells in sheep. Blood 1998; 91: 3688-92.
30. Conneally E, Cashman J, Petzer A, Eaves C. Expansion in vitro of transplantable human cord blood stem cells demonstrated using a quantitative assay of their lympho-myeloid repopulating activity in nonobese diabetic-scid/scid mice. Proc Natl Acad Sci U S A 1997; 94: 9836-41.
31. Bhatia M, Bonnet D, Kapp U, Wong JC, Murdoch B, Dick JE. Quantitative analysis reveals expansion of human hematopoietic repopulathig cells after short-term ex vivo culture. J Exp Med 1997; 186: 619-24.
32. Piacibello W, Sanavio F, Severino A, et al. Engraftment in nonobese diabetic severe combined immunodeficient mice of human CD34(+) cord blood cells after ex vivo expansion: evidence for the amplification and self-renewal of repopulating stem cells. Blood 1999; 93: 3736-49.
33. Nolta JA, Thiemann FT, Arakawa-Hoyt J, et al. The AFT024 stromal cell line supports long-tem ex vivo maintenance of engrafting multipotent human hematopoietic progenitors. Leukemia 2002; 16: 352-61.
34. Moore KA, Ema H, Lemischka IR. In vitro maintenance of highly purified, transplantable hematopoietic stem cells. Blood 1997; 89: 4337-47.
35. Shih CC, Hu MC, Hu J, Medeiros J, Forman SJ. Long-term ex vivo maintenance and expansion of transplantable human hematopoietic stem cells. Blood 1999; 94: 1623-36.
36. Punzel M, Moore KA, Lemischka IR, Verfaillie CM. The type of stromal feeder used in limiting dilution assays influences frequency and maintenance assessment of human long-term culture initiating cells. Leukemia 1999; 13: 92-7.
37. Karanu FN, Murdoch B, Gallacher L, et al. The notch ligand jagged-1 represents a novel growth factor of human hematopoietic stem cells. J Exp Med 2000; 192: 1365-72.
38. Karanu FN, Murdoch B, Miyabayashi T, et al. Human homologues of Delta-1 and Delta-4 function as mitogenic regulators of primitive human hematopoietic cells. Blood 2001; 97: 1960-7.
39. Varnum-Finney B, Brashem-Stein C, Bernstein ID. Combined effects of Notch signaling and cytokines induce a multiple log increase in precursors with lymphoid and myeloid reconstituting ability. Blood 2003; 101: 1784-9.
40. Murdoch B, Chadwick K, Martin M, et al. Wnt-5A augments repopulating capacity and primitive hematopoietic development of human blood stem cells in vivo. Proc Natl Acad Sci U S A 2003; 100: 3422-7.
41. Reya T, Duncan AW, Ailles L, et al. A role for Wnt signalling in self-renewal of haematopoietic stem cells. Nature 2003; 423: 409-14.
42. North TE, Goessling W, Walkley CR, et al. Prostaglandin E2 regulates vertebrate haematopoietic stem cell homeostasis. Nature 2007; 447: 1007-11.
43. Schofield R. The relationship between the spleen colony-forming cell and the haemopoietic stem cell. Blood Cells 1978; 4: 7-25.
44. Calvi LM, Adams GB, Weibrecht KW, et al. Osteoblastic cells regulate the haematopoietic stem cell niche. Nature 2003; 425: 841-6.
45. Zhang J, Niu C, Ye L, et al. Identification of the haematopoietic stem cell niche and control of the niche size. Nature 2003; 425: 836-41.
46. Kiel MJ, Yilmaz OH, Iwashita T, Terhorst C, Morrison SJ. SLAM family receptors distinguish hematopoietic stem and progenitor cells and reveal endothelial niches for stem cells. Cell 2005; 121: 1109-21.
47. Taichman RS. Blood and bone: two tissues whose fates are inter-twined to create the hematopoietic stem-cell niche. Blood 2005; 105: 2631-9.
48. Haylock DN, Nilsson SK. Stem cell regulation by the hematopoietic stem cell niche. Cell Cycle 2005; 4: 1353-5.
49. Suda T, Arai F, Hirao A: Hematopoietic stem cells and their niche. Trends Immunol. 2005; 26: 426-33.
50. Arai F, Hirao A, Suda T. Regulation of hematopoiesis and its inter-action with stem cell niches. Int J Hematol 2005; 82: 371-6.
51. Nilsson SK, Simmons PJ. Transplantable stem cells: home to specific niches. Curr Opin Hematol 2004; 11: 102-6.
52. Moore KA, Lemischka IR. Stem cells and their niches. Science 2006; 311: 1880-5.
53. Kaplan RN, Psaila B, Lyden D. Niche-to-niche migration of bone-marrow-derived cells. Trends Mol Med 2007; 13: 72-81.
54. Adams GB, Scadden DT. The hematopoietic stem cell in its place. Nat Immunol 2006; 7: 333-7.
55. Yin T, Li L, The stem cell niches in bone. J Clin Invest 2006; 116: 1195-201.
56. Ross J, Li L. Recent advances in understanding extrinsic control of hematopoietic stem cell fate. Curr Opin Hematol 2006; 13: 237-42.
57. Scadden DT: The stem-cell niche as an entity of action. Nature 2006; 441: 1075-9.
58. Rizo A, Vellenga, E, de Haan G, Schuringa JJ. Signaling pathways in self-renewing hematopoietic and leukemic stem cells: do all stem cells need a niche? Hum Mol Genet 2006;, 15 Spec No 2: R210-9.
59. Li Z, Li L. Understanding hematopoietic stem-cell microenvironments. Trends Biochem Sci 2006; 31: 589-95.
60. Arai F, Hirao A, Ohmura M, et al. Tie2/Angiopoietin-1 signaling regulates hematopoietic stem cell quiescence in the bone marrow niche. Cell 2004; 118: 149-61.
61. Kojika S, Griffin JD. Notch receptors and hematopoiesis. Exp Hematol 2001; 29: 1041-52.
62. Suzuki T, Chiba S: Notch signaling in hematopoietic stem cells. Int J Hematol 2005; 82: 285-94.
63. Milner LA, Bigas A. Notch as a mediator of cell fate determination in hematopoiesis: evidence and speculation. Blood 1999; 93: 2431-48.
64. Milner LA, Kopan R, Martin DI, Bernstein ID. A human homologue of the Drosophila developmental gene, Notch, is expressed in CD34+ hematopoietic precursors. Blood 1994; 83: 2057-62.
65. Ohishi K, Varnum-Finney B, Flowers D, Anasetti C, Myerson D, Bernstein ID. Monocytes express high amounts of Notch and undergo cytokine specific apoptosis following interaction with the Notch ligand, Delta-1. Blood 2000; 95: 2847-54.
66. Leary AG, Strauss LC, Civin CI, Ojawa M. Disparate differentiation in hemopoietic colonies derived from human paired progenitors. Blood 1985; 66: 327-32.
67. Suda J, Suda T, Ogawa M. Analysis of differentiation of mouse hemopoietic stem cells in culture by sequential replating of paired progenitors. Blood 1984; 64: 393-9.
68. Suds T, Suda J, Ogawa M. Disparate differentiation in mouse hemopoietic colonies derived from paired progenitors. Proc Natl Acad Sci U S A 1984; 81: 2520-4.
69. Mayani H, Dragowska W, Lansdorp PM. Lineage commitment in human hemopoiesis involves asymmetric cell division of multipotent progenitors and does not appear to be influenced by cytokines. J Cell Physiol 1993; 157: 579-86.
70. Brummendorf TH, Dragowska W, Zijlmans J, Thombury G, Lansdorp PM. Asymmetric cell divisions sustain long-term hematopoiesis from single-sorted human fetal liver cells. J Exp Med 1998; 188: 1117-24.
71. Huang S, Law P, Francis K, Palsson BO, Ho AD. Symmetry of initial cell divisions among primitive hematopoietic progenitors is independent of ontogenic age and regulatory molecules. Blood 1999; 94: 2595-604.
72. Punzel M, Zhang T, Liu D, Eckstein V, Ho AD. Functional analysis of initial cell divisions defines the subsequent fate of individual human CD34(+)CD38(-) cells. Exp Hematol 2002; 30: 464-72.
73. Punzel M, Wissink SD, Miller JS, Moore KA, Lemischka IR, Verfaillie CM. The myeloid-lymphoid initiating cell (ML-IC) assay assesses the fate of multipotent human progenitors in vitro. Blood 1999; 93: 3750-6.
74. Giebel B, Zhang T, Beckmann J, et al. Primitive human hematopoietic cells give rise to differentially specified daughter cells upon their initial cell division. Blood 2006; 107: 2146-52.
75. Giebel B. The notch signaling pathway is required to specify muscle progenitor cells in Drosophila. Mech Dev 1999; 86: 137-45.
76. Artavanis-Tsakonas S, Rand MD, Lake RJ: Notch signaling: cell fate control and signal integration in development. Science 1999; 284: 770-6.
77. Yin AH, Miraglia S, Zanjani ED, et al. AC133, a novel marker for human hematopoietic stem and progenitor cells. Blood 1997; 90: 5002-12.
78. Miraglia S, Godfrey W, Yin AH, et al. A novel five-transmembrane hematopoietic stem cell antigen: isolation, characterization, and molecular cloning. Blood 1997; 90: 5013-21.
79. Krause DS, Fackler MJ, Civin CI, May WS. CD34: structure, biology, and clinical utility. Blood 1996, 87: 1-13.
80. Giebel B, Corbeil D, Beckmann J, et al. Segregation of lipid raft markers including CD133 in polarized human hematopoietic stem and progenitor cells. Blood 2004; 104: 2332-8.
81. Beckmann J, Scheitza S, Wernet P, Fischer JC, Giebel B. Asymmetric cell division within the human hematopoietic stem and progenitor cell compartment: identification of asymmetrically segregating proteins. Blood 2007; 109: 5494-501.
82. von Levetzow G, Spanholtz J, Beckmann J, et al. Nucleofection, an efficient nonviral method to transfer genes into human hematopoietic stem and progenitor cells. Stem Cells Dev 2006; 15: 278-85.
83. Giebel B, Beckmann J. Asymmetric cell divisions of human hematopoietic stem and progenitor cells meet endosomes. Cell Cycle 2007; 6: 2201-04.
84. Punzel M, Liu D, Zhang T, Eckstein V, Miesala K, Ho AD. The symmetry of initial divisions of human hematopoietic progenitors is altered only by the cellular microenviromment. Exp Hematol 2003; 31: 339-47.
85. Chang JT, Palanivel VR, Kinjyo I, et al. Asymmetric T lymphocyte division in the initiation of adaptive immune responses. Science 2007; 315: 1687-91.
86. Bullock TE, Wen B, Marley SB, Gordon MY. Potential of CD34 in the regulation of symmetrical and asymmetrical divisions by hematopoietic progenitor cells. Stem Cells 2007; 25: 844-51.
87. Bruce WP, Van Der Gaag H. A Quantitative Assay for the Number of Murine Lymphoma Cells Capable of Proliferation in vivo. Nature 1963; 199: 79-80.
88. Wang JC, Dick JE. Cancer stem cells: lessons from leukemia. Trends Cell Biol 2005; 15: 494-501.
89. Clarke MF, Dick JE, Dirks PB, et al. Cancer Stem Cells-Perspectives on Current Swas and Future Directions: AACR Workshop on Cancer Stem Cells. Cancer Res 2006; 66: 9339-44.
90. Buzzeo MP, Scott EW, Cogle CR. The hunt for cancer-initiating cells: a history stemming from leukemia. Leukemia 2007; 21: 1619-27.
91. Lapidot T, Sirard C, Vormoor J, et al. A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature 1994; 367: 645-8.
92. Bonnet D, Dick JE. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med 1997; 3: 730-7.
93. Hope KJ, Jin L, Dick JE. Acute myeloid leukemia originates from a hierarchy of leukemic stem cell classes that differ in self-renewal capacity. Nat Immunol. 2004; 5: 738-43.
94. Tenen DG. Disruption of differentiation in human cancer. AML shows the way. Nat Rev Cancer 2003; 3: 89-101.
95. Dick JE. Acute myeloid leukemia stem cells. Ann N Y Acad Sci 2005; 1044: 1-5.
96. Lapidot T, Kollet O. The essential roles of the chemokine SDF-1 and its receptor CXCR4 in human stem cell homing and repopulation of transplanted immune-deficient NOD/SCID and NOD/SCID/B2m(null) mice. Leukemia 2002; 16: 1992-2003.
97. Teixido J, Hemler ME, Greenberger JS, Anklesaria P. Role of beta 1 and beta 2 integrins in the adhesion of human CD34hi stem cells to bone marrow stroma. J Clin Invest 1992; 90: 358-67.
98. Burger JA, Burkle A. The CXCR4 chemokine receptor in acute and chronic leukaemia: a marrow homing receptor and potential therapeutic target Br J Haematol 2007; 137: 288-96.
99. Lapidot T, Dar A, Kollet O. How do stem cells find their way home? Blood 2005; 106: 1901-10.
100. Jin L, Hope KJ, Zhai Q, Smadja-Joffe F, Dick JE. Targeting of CD44 eradicates human acute myeloid leukemic stem cells. Nat Med 2006; 12: 1167-74.
101. Krause DS, Lazarides K, von Andrian UH, Van Etten RA. Requirement for CD44 in homing and engraftment of BCR-ABL-expressing leukemic stem cells. Nat Med 2006; 12: 1175-80.
102. Willert K, Brown JD, Danenberg E, et al. Wnt proteins are lipid-modified and can act as stem cell growth factors. Nature 2003; 423: 448-52.
103. Austin TW, Solar GP, Ziegler FC, Liem L, Matthews W. A role for the Wnt gene family in hematopoiesis: expansion of multilineage progenitor cells. Blood 1997; 89: 3624-35.
104. Van Don Berg DJ, Sharma AK, Bruno E, Hoffman R. Role of members of the Wnt gene family in human hematopoiesis. Blood 1998; 92: 3189-202.
105. Trowbridge JJ, Xenocostas A, Moon RT, Bhatia M. Glycogen synthase kinase-3 is an in vivo regulator of hematopoietic stem cell repopulation. Nat Med 2006; 12: 89-98.
106. Reya T, Clevers H. Wnt signalling in stem cells and cancer. Nature 2005; 434: 843-50.
107. Coluccia AM, Vacca A, Dunach K et al. Bct-Abl stabilizes beta-catenin in chronic myeloid leukemia through its tyrosine phosphorylation. EMBO J 2007; 26: 1456-66.
108. Jamieson CH, Ailles LE, Dylla SJ, et al. Granulocyte-macrophage progenitors as candidate leukemic stem cells in blast-crisis CML. N Engl J Med 2004; 351: 657-67.
109. Scheller M, Huelsken J, Rosenbauer F, et al. Hematopoietic stem cell and multilineage defects generated by constitutive beta-catenin activation. Nat Immunol 2006; 7: 1037-47.
110. Kirstetter P, Anderson K, Porse BT, Jacobsen SE, Nerlov C. Activation of the canonical Wnt pathway leads to loss of hematopoietic stem cell repopulation and multilineage differentiation block. Nat Immunol 2006; 7: 1048-56.
111. Zheng X, Beissert T, Kukoc-Zivojnov N, et al. Gamma-catenin contributes to leukemogenesis induced by AML-associated translocation products by increasing the self-renewal of very primitive progenitor cells. Blood 2004; 103: 3535-43.
112. Simon M, Grandage VL, Linch DC, Khwaja A. Constitutive activation of the Wnt/beta-catenin signalling pathway in acute myeloid leukaemia. Oncogene 2005; 24: 2410-20.
113. Ysebaert L, Chicanne G, Demur C, et al. Expression of beta-catenin by acute myeloid leukemia cells predicts enhanced clonogenic capacities and poor prognosis. Leukemia 2006; 20: 1211-6.
114. Duncan AW, Rattis FM, DiMascio et al. Integration of Notch and Wnt signaling in hematopoietic stem cell maintenance. Nat Immunol 2005; 6: 314-22.
115. Abramovich C, Humphries RK. Hox regulation of normal and leukemic hematopoietic stem cells. Curr Opin Hematol 2005; 12: 2110-6.
116. Rosenbauer F, Tenen DG. Transcription factors in myeloid development: balancing differentiation with transformation. Nat Rev Immunol 2007; 7: 105-17.
117. Raaphorst FM. Self-renewal of hematopoietic: and leukemic stem cells: a central role for the Polycomb-group gene Bmi-1. Trends Immunol 2003; 24: 522-4.
118. Lessard J, Sauvageau G. Bmi-1 determines the proliferative-capacity of normal and leukaemic stem cells. Nature 2003; 423: 255-60.
119. Park IK, Qian D, Kiel M, et al. Bmi-1 is required for maintenance of adult self-renewing haematopoietic stem cells. Nature 2003; 423: 302-5.
120. Wodarz A. Molecular control of cell polarity and asymmetric cell division in Drosophila neuroblasts. Curr Opin Cell Biol 2005; 17: 475-81.
121. Lee CY, Wilkinson BD, Siegrist SE, Wharton RP, Doe CQ. Brat is a Miranda cargo protein that promotes neuronal differentiation and inhibits neuroblast self-renewal. Dev Cell 2006; 10: 441-9.
122. Betschinger J, Mechtler K, Knoblich JA. Asymmetric segregation of the tumor suppressor brat regulates self-renewal in Drosophila neural stem cells. Cell 2006; 124: 1241-53.
123. Gateff E. Tumor suppressor and overgrowth suppressor genes of Drosophila melanogaster: developmental aspects. Int J Dev Biol 1994; 38: 565-90.
124. Caussinus E, Gonzalez C. Induction of tumor growth by altered stem-cell asymmetric division in Drosophila melanogaster. Nat Genet 2005; 37: 1125-9.
125. Li L, Vaessin H. Pan-neural Prospero terminates cell proliferation during Drosophila, neurogenesis. Genes Dev 2000; 14: 147-51.
126. Sonoda J, Wharton RP. Drosophila Brain Tumor is a translational repressor. Genes Dev 2001; 15: 762-73.